{
    "2018-12-19": [
        [
            {
                "time": "",
                "original_text": "至暗时刻丨从天堂到地狱 2018医药股八大黑天鹅事件",
                "features": {
                    "keywords": [
                        "至暗时刻",
                        "黑天鹅事件",
                        "医药股"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "美年健康：美年健康首次回购 彰显发展信心",
                "features": {
                    "keywords": [
                        "美年健康",
                        "首次回购",
                        "发展信心"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业连锁医疗系列对比之二:基于通策医疗、爱尔眼科、美年健康的比较分析,消费需求新趋势,连锁医疗价值依旧",
                "features": {
                    "keywords": [
                        "医药行业",
                        "连锁医疗",
                        "消费需求",
                        "新趋势",
                        "价值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周观点:带量采购试点落地、辅助用药管理通知出台,政策主导医药板块加速完成调整",
                "features": {
                    "keywords": [
                        "医药行业",
                        "带量采购",
                        "辅助用药管理",
                        "政策主导",
                        "调整"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}